Table 1.
Clinicopathologic characteristics and GOLPH3 expression of patients with clinically N0 oral tongue cancer of the study cohort (n = 179)
| Characteristics | Number of cases (%) |
|---|---|
|
Gender |
|
| Male |
109 (60.9) |
| Female |
70 (39.1) |
|
Age (years) |
|
| < 53 |
89 (49.7) |
| ≥ 53 |
90 (50.3) |
|
Pathologic stage |
|
|
I |
80 (44.7) |
|
II |
67 (37.4) |
|
III |
17 (9.5) |
|
IV |
15 (8.4) |
|
T classification |
|
| T1 |
87 (48.6) |
| T2 |
87 (48.6) |
| T3 |
5 (2.8) |
|
N classification |
|
| N0 |
149 (83.2) |
| N1 |
15 (8.4) |
| N2 |
15 (8.4) |
|
Nodal status |
|
| N0 |
149 (83.2) |
| N + (N1 and N2) |
30 (16.8) |
|
Pathologic differentiation |
|
| Well |
136 (76.0) |
| Moderately |
36 (20.1) |
| Poorly |
7 (3.9) |
|
Recurrence |
|
| No |
123 (68.7) |
| Yes |
56 (31.3) |
|
Vital status (at follow-up) |
|
| Alive |
131 (73.2) |
| Dead |
48 (26.8) |
|
Expression of GOLPH3 |
|
| Low or none expression |
57 (31.8) |
| High expression | 122 (68.2) |